154 related articles for article (PubMed ID: 20065617)
1. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
Maitani T; Saitoh H
Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
[No Abstract] [Full Text] [Related]
2. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
[TBL] [Abstract][Full Text] [Related]
3. The toxic oil syndrome: 20 years on.
Diggle GE
Int J Clin Pract; 2001; 55(6):371-5. PubMed ID: 11501225
[TBL] [Abstract][Full Text] [Related]
4. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism.
Aldridge WN
Toxicol Lett; 1992 Dec; 64-65 Spec No():59-70. PubMed ID: 1471212
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Kaufman LD; Krupp LB
Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
[TBL] [Abstract][Full Text] [Related]
6. Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome.
Williamson BL; Tomlinson AJ; Hurth KM; Posada de la Paz M; Gleich GJ; Naylor S
Biomed Chromatogr; 1998; 12(5):255-61. PubMed ID: 9787895
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Bolster MB; Silver RM
Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM
Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
[TBL] [Abstract][Full Text] [Related]
9. 3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?
Philen RM; Hill RH
Mayo Clin Proc; 1993 Feb; 68(2):197-200. PubMed ID: 8423703
[No Abstract] [Full Text] [Related]
10. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM
Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
[TBL] [Abstract][Full Text] [Related]
12. The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
Hertzman PA
Adv Exp Med Biol; 1996; 398():339-42. PubMed ID: 8906286
[No Abstract] [Full Text] [Related]
13. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
[TBL] [Abstract][Full Text] [Related]
14. [Fasciitis, perimyositis, microangiopathy].
Goto K; Kumamoto T
Ryoikibetsu Shokogun Shirizu; 2001; (36):271-4. PubMed ID: 11596388
[No Abstract] [Full Text] [Related]
15. [Eosinophilia-myalgia: new syndrome].
Szechiński J; Borysewicz K
Postepy Hig Med Dosw; 1992; 46(3):319-25. PubMed ID: 1369828
[TBL] [Abstract][Full Text] [Related]
16. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
Silver RM; Sutherland SE; Carreira P; Heyes MP
J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
[TBL] [Abstract][Full Text] [Related]
17. Immunological aspects of the toxic oil syndrome.
Lahoz C; del Pozo V; Gallardo S; Cárdaba B; Jurado A; Cortegano I; del Amo A; Arrieta I; Palomino P
Arch Toxicol Suppl; 1997; 19():65-73. PubMed ID: 9079195
[No Abstract] [Full Text] [Related]
18. Study of apoptosis in human lymphocytes by toxic substances implicated in toxic oil syndrome.
Gallardo S; Cárdaba B; del Pozo V; de Andrés B; Cortegano I; Jurado A; Tramón P; Palomino P; Lahoz C
Toxicology; 1997 Mar; 118(1):71-82. PubMed ID: 9074655
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of eosinophilia myalgia syndrome and related disorders.
Clauw DJ
Adv Exp Med Biol; 1996; 398():331-8. PubMed ID: 8906285
[TBL] [Abstract][Full Text] [Related]
20. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism.
del Pozo V; de Andrés B; Gallardo S; Cárdaba B; de Arruda-Chaves E; Cortegano MI; Jurado A; Palomino P; Oliva H; Aguilera B; Posada M; Lahoz C
Toxicology; 1997 Mar; 118(1):61-70. PubMed ID: 9074654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
